 | • レポートコード：QY20ST-07293 • 出版社/出版日：QYResearch / 2020年9月15日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、134ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥580,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥870,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,160,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、世界のモンテルカスト中間体市場について種類別（GMP、非GMP）、用途別（喘息、アレルギー性鼻炎、気管支痙攣、じんましん）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・モンテルカスト中間体市場の概要 ・世界の主要地域別モンテルカスト中間体市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のモンテルカスト中間体市場規模2015-2026：種類別（GMP、非GMP） ・世界のモンテルカスト中間体市場規模2015-2026：用途別（喘息、アレルギー性鼻炎、気管支痙攣、じんましん） ・モンテルカスト中間体の北米市場規模2015-2020 ・モンテルカスト中間体のヨーロッパ市場規模2015-2020 ・モンテルカスト中間体の中国市場規模2015-2020 ・モンテルカスト中間体の日本市場規模2015-2020 ・モンテルカスト中間体の東南アジア市場規模2015-2020 ・モンテルカスト中間体のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・モンテルカスト中間体の製造コスト分析 ・販売チャネル、流通業者、顧客 ・モンテルカスト中間体の市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Montelukast Intermediate Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Montelukast Intermediate market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Montelukast Intermediate is a leukotriene receptor antagonist (LTRA)
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Montelukast Intermediate market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Montelukast Intermediate industry.
Based on our recent survey, we have several different scenarios about the Montelukast Intermediate YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 5019.7 million in 2019. The market size of Montelukast Intermediate will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Montelukast Intermediate market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Montelukast Intermediate market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Montelukast Intermediate market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Montelukast Intermediate market. The report also includes nautical information, where it shows Montelukast Intermediate market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Montelukast Intermediate market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Montelukast Intermediate market.
Montelukast Intermediate used to prevent wheezing, difficulty in breathing, chest tightness, and coughing caused by asthma.
Geographical Analysis:
Based on region, the global Montelukast Intermediate market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Montelukast Intermediate market are
VIVAN Life Sciences
P.G. Shah & Co.
Manus Aktteva Biopharma
Ortin Laboratories
…
Segment by Type
GMP
Non-GMP
Segment by Application
Asthma
Allergic Rhinitis
Bronchospasm
Urticaria
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Montelukast Intermediate market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Montelukast Intermediate market.
• The market share of the global Montelukast Intermediate market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Montelukast Intermediate market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Montelukast Intermediate market.
1 Montelukast Intermediate Market Overview
1.1 Montelukast Intermediate Product Scope
1.2 Montelukast Intermediate Segment by Type
1.2.1 Global Montelukast Intermediate Sales by Type (2020-2026)
1.2.2 GMP
1.2.3 Non-GMP
1.3 Montelukast Intermediate Segment by Application
1.3.1 Global Montelukast Intermediate Sales Comparison by Application (2020-2026)
1.3.2 Asthma
1.3.3 Allergic Rhinitis
1.3.4 Bronchospasm
1.3.5 Urticaria
1.4 Montelukast Intermediate Market Estimates and Forecasts (2015-2026)
1.4.1 Global Montelukast Intermediate Sales Growth Rate (2015-2026)
1.4.2 Global Montelukast Intermediate Revenue and Growth Rate (2015-2026)
1.4.3 Global Montelukast Intermediate Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Montelukast Intermediate Industry Impact
1.5.1 How the Covid-19 is Affecting the Montelukast Intermediate Industry
1.5.1.1 Montelukast Intermediate Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Montelukast Intermediate Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Montelukast Intermediate Players to Combat Covid-19 Impact
2 Montelukast Intermediate Estimate and Forecast by Region
2.1 Global Montelukast Intermediate Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Montelukast Intermediate Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Montelukast Intermediate Sales Market Share by Region (2015-2020)
2.2.2 Global Montelukast Intermediate Revenue Market Share by Region (2015-2020)
2.3 Global Montelukast Intermediate Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Montelukast Intermediate Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Montelukast Intermediate Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Montelukast Intermediate Estimates and Projections (2015-2026)
2.4.2 Europe Montelukast Intermediate Estimates and Projections (2015-2026)
2.4.3 China Montelukast Intermediate Estimates and Projections (2015-2026)
2.4.4 Japan Montelukast Intermediate Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Montelukast Intermediate Estimates and Projections (2015-2026)
2.4.6 India Montelukast Intermediate Estimates and Projections (2015-2026)
3 Global Montelukast Intermediate Competition Landscape by Players
3.1 Global Top Montelukast Intermediate Players by Sales (2015-2020)
3.2 Global Top Montelukast Intermediate Players by Revenue (2015-2020)
3.3 Global Montelukast Intermediate Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Montelukast Intermediate as of 2019)
3.4 Global Montelukast Intermediate Average Price by Company (2015-2020)
3.5 Manufacturers Montelukast Intermediate Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Montelukast Intermediate Players (Opinion Leaders)
4 Global Montelukast Intermediate Market Size by Type
4.1 Global Montelukast Intermediate Historic Market Review by Type (2015-2020)
4.1.1 Global Montelukast Intermediate Sales Market Share by Type (2015-2020)
4.1.2 Global Montelukast Intermediate Revenue Market Share by Type (2015-2020)
4.1.3 Global Montelukast Intermediate Price by Type (2014-2020)
4.2 Global Montelukast Intermediate Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Montelukast Intermediate Sales Forecast by Type (2021-2026)
4.2.2 Global Montelukast Intermediate Revenue Forecast by Type (2021-2026)
4.2.3 Global Montelukast Intermediate Price Forecast by Type (2021-2026)
5 Global Montelukast Intermediate Market Size by Application
5.1 Global Montelukast Intermediate Historic Market Review by Application (2015-2020)
5.1.1 Global Montelukast Intermediate Sales Market Share by Application (2015-2020)
5.1.2 Global Montelukast Intermediate Revenue Market Share by Application (2015-2020)
5.1.3 Global Montelukast Intermediate Price by Application (2015-2020)
5.2 Global Montelukast Intermediate Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Montelukast Intermediate Sales Forecast by Application (2021-2026)
5.2.2 Global Montelukast Intermediate Revenue Forecast by Application (2021-2026)
5.2.3 Global Montelukast Intermediate Price Forecast by Application (2021-2026)
3 North America Montelukast Intermediate Market Facts & Figures
3.2 North America Montelukast Intermediate Sales Market Share by Company (2015-2020)
3.3 North America Montelukast Intermediate Sales Market Share by Type (2015-2020)
3.4 North America Montelukast Intermediate Sales Market Share by Application (2015-2020)
4 Europe Montelukast Intermediate Market Facts & Figures
4.2 Europe Montelukast Intermediate Sales Market Share by Company (2015-2020)
4.3 Europe Montelukast Intermediate Sales Market Share by Type (2015-2020)
4.4 Europe Montelukast Intermediate Sales Market Share by Application (2015-2020)
5 China Montelukast Intermediate Market Facts & Figures
5.2 China Montelukast Intermediate Sales Market Share by Company (2015-2020)
5.3 China Montelukast Intermediate Sales Market Share by Type (2015-2020)
5.4 China Montelukast Intermediate Sales Market Share by Application (2015-2020)
6 Japan Montelukast Intermediate Market Facts & Figures
6.2 Japan Montelukast Intermediate Sales Market Share by Company (2015-2020)
6.3 Japan Montelukast Intermediate Sales Market Share by Type (2015-2020)
6.4 Japan Montelukast Intermediate Sales Market Share by Application (2015-2020)
7 Southeast Asia Montelukast Intermediate Market Facts & Figures
7.2 Southeast Asia Montelukast Intermediate Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Montelukast Intermediate Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Montelukast Intermediate Sales Market Share by Application (2015-2020)
8 India Montelukast Intermediate Market Facts & Figures
8.2 India Montelukast Intermediate Sales Market Share by Company (2015-2020)
8.3 India Montelukast Intermediate Sales Market Share by Type (2015-2020)
8.4 India Montelukast Intermediate Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Montelukast Intermediate Business
12.1 VIVAN Life Sciences
12.1.1 VIVAN Life Sciences Montelukast Intermediate Corporation Information
12.1.2 VIVAN Life Sciences Montelukast Intermediate Business Overview and Total Revenue
12.1.3 VIVAN Life Sciences Montelukast Intermediate Sales, Revenue and Gross Margin (2015-2020)
12.1.4 VIVAN Life Sciences Montelukast Intermediate Products Offered
12.1.5 VIVAN Life Sciences Recent Development
12.2 P.G. Shah & Co.
12.2.1 P.G. Shah & Co. Montelukast Intermediate Corporation Information
12.2.2 P.G. Shah & Co. Montelukast Intermediate Business Overview and Total Revenue
12.2.3 P.G. Shah & Co. Montelukast Intermediate Sales, Revenue and Gross Margin (2015-2020)
12.2.4 P.G. Shah & Co. Montelukast Intermediate Products Offered
12.2.5 P.G. Shah & Co. Recent Development
12.3 Manus Aktteva Biopharma
12.3.1 Manus Aktteva Biopharma Montelukast Intermediate Corporation Information
12.3.2 Manus Aktteva Biopharma Montelukast Intermediate Business Overview and Total Revenue
12.3.3 Manus Aktteva Biopharma Montelukast Intermediate Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Manus Aktteva Biopharma Montelukast Intermediate Products Offered
12.3.5 Manus Aktteva Biopharma Recent Development
12.4 Ortin Laboratories
12.4.1 Ortin Laboratories Montelukast Intermediate Corporation Information
12.4.2 Ortin Laboratories Montelukast Intermediate Business Overview and Total Revenue
12.4.3 Ortin Laboratories Montelukast Intermediate Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Ortin Laboratories Montelukast Intermediate Products Offered
12.4.5 Ortin Laboratories Recent Development
…
13 Montelukast Intermediate Manufacturing Cost Analysis
13.1 Montelukast Intermediate Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Montelukast Intermediate
13.4 Montelukast Intermediate Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Montelukast Intermediate Distributors List
14.3 Montelukast Intermediate Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Montelukast Intermediate Sales (MT) Growth Rate by Type (2020-2026)
Table 2. Global Montelukast Intermediate Sales (MT) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Montelukast Intermediate Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Montelukast Intermediate Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Montelukast Intermediate Players to Combat Covid-19 Impact
Table 8. Global Market Montelukast Intermediate Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Montelukast Intermediate Sales (MT) by Region (2015-2020)
Table 10. Global Montelukast Intermediate Sales Market Share by Region (2015-2020)
Table 11. Global Montelukast Intermediate Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Montelukast Intermediate Revenue Share by Region (2015-2020)
Table 13. Global Montelukast Intermediate Sales (MT) Forecast by Region (2021-2026)
Table 14. Global Montelukast Intermediate Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Montelukast Intermediate Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Montelukast Intermediate Revenue Share Forecast by Region (2021-2026)
Table 17. Global Montelukast Intermediate (MT) of Key Companies (2015-2020)
Table 18. Global Montelukast Intermediate Sales Share by Company (2015-2020)
Table 19. Global Montelukast Intermediate Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Montelukast Intermediate Revenue Share by Company (2015-2020)
Table 21. Global Montelukast Intermediate by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Montelukast Intermediate as of 2019)
Table 22. Global Montelukast Intermediate Average Price (USD/MT) of Key Company (2015-2020)
Table 23. Manufacturers Montelukast Intermediate Manufacturing Sites and Area Served
Table 24. Manufacturers Montelukast Intermediate Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Montelukast Intermediate Players
Table 27. Global Montelukast Intermediate Sales (MT) by Type (2015-2020)
Table 28. Global Montelukast Intermediate Sales Share by Type (2015-2020)
Table 29. Global Montelukast Intermediate Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Montelukast Intermediate Price (MT) by Type (2015-2020)
Table 31. Global Montelukast Intermediate Sales Share by Type (2021-2026)
Table 32. Global Montelukast Intermediate Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Montelukast Intermediate Revenue Share by Type (2021-2026)
Table 34. Global Montelukast Intermediate Price (MT) by Type (2021-2026)
Table 35. Global Montelukast Intermediate Sales (MT) by Application (2015-2020)
Table 36. Global Montelukast Intermediate Sales Share by Application (2015-2020)
Table 37. Global Montelukast Intermediate Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Montelukast Intermediate Price (MT) by Application (2015-2020)
Table 39. Global Montelukast Intermediate Sales (MT) by Application (2021-2026)
Table 40. Global Montelukast Intermediate Sales Share by Application (2021-2026)
Table 41. Global Montelukast Intermediate Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Montelukast Intermediate Revenue Share by Application (2021-2026)
Table 43. Global Montelukast Intermediate Price (MT) by Application (2021-2026)
Table 44. United States Montelukast Intermediate Sales (MT) by Company (2015-2020)
Table 45. United States Montelukast Intermediate Sales Market Share by Company (2015-2020)
Table 46. United States Montelukast Intermediate Sales (MT) by Type (2015-2020)
Table 47. United States Montelukast Intermediate Sales Market Share by Type (2015-2020)
Table 48. United States Montelukast Intermediate Sales (MT) by Application (2015-2020)
Table 49. United States Montelukast Intermediate Sales Market Share by Application (2015-2020)
Table 50. Europe Montelukast Intermediate Sales (MT) by Company (2015-2020)
Table 51. Europe Montelukast Intermediate Sales Market Share by Company (2015-2020)
Table 52. Europe Montelukast Intermediate Sales (MT) by Type (2015-2020)
Table 53. Europe Montelukast Intermediate Sales Market Share by Type (2015-2020)
Table 54. Europe Montelukast Intermediate Sales (MT) by Application (2015-2020)
Table 55. Europe Montelukast Intermediate Sales Market Share by Type (2015-2020)
Table 56. China Montelukast Intermediate Sales (MT) by Company (2015-2020)
Table 57. China Montelukast Intermediate Sales Market Share by Company (2015-2020)
Table 58. China Montelukast Intermediate Sales (MT) by Type (2015-2020)
Table 59. China Montelukast Intermediate Sales Market Share by Type (2015-2020)
Table 60. China Montelukast Intermediate Sales (MT) by Application (2015-2020)
Table 61. China Montelukast Intermediate Sales Market Share by Application (2015-2020)
Table 62. Japan Montelukast Intermediate Sales (MT) by Company (2015-2020)
Table 63. Japan Montelukast Intermediate Sales Market Share by Company (2015-2020)
Table 64. Japan Montelukast Intermediate Sales (MT) by Type (2015-2020)
Table 65. Japan Montelukast Intermediate Sales Market Share by Type (2015-2020)
Table 66. Japan Montelukast Intermediate Sales (MT) by Application (2015-2020)
Table 67. Japan Montelukast Intermediate Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Montelukast Intermediate Sales (MT) by Company (2015-2020)
Table 69. Southeast Asia Montelukast Intermediate Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Montelukast Intermediate Sales (MT) by Type (2015-2020)
Table 71. Southeast Asia Montelukast Intermediate Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Montelukast Intermediate Sales (MT) by Type (2015-2020)
Table 73. Southeast Asia Montelukast Intermediate Sales Market Share by Application (2015-2020)
Table 74. India Montelukast Intermediate Sales (MT) by Company (2015-2020)
Table 75. India Montelukast Intermediate Sales Market Share by Company (2015-2020)
Table 76. India Montelukast Intermediate Sales (MT) by Type (2015-2020)
Table 77. India Montelukast Intermediate Sales Market Share by Type (2015-2020)
Table 78. India Montelukast Intermediate Sales (MT) by Application (2015-2020)
Table 79. India Montelukast Intermediate Sales Market Share by Application (2015-2020)
Table 80. VIVAN Life Sciences Corporation Information
Table 81. VIVAN Life Sciences Description and Business Overview
Table 82. VIVAN Life Sciences Montelukast Intermediate Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. VIVAN Life Sciences Montelukast Intermediate Product
Table 84. VIVAN Life Sciences Recent Development
Table 85. P.G. Shah & Co. Corporation Information
Table 86. P.G. Shah & Co. Description and Business Overview
Table 87. P.G. Shah & Co. Montelukast Intermediate Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. P.G. Shah & Co. Montelukast Intermediate Product
Table 89. P.G. Shah & Co. Recent Development
Table 90. Manus Aktteva Biopharma Corporation Information
Table 91. Manus Aktteva Biopharma Description and Business Overview
Table 92. Manus Aktteva Biopharma Montelukast Intermediate Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Manus Aktteva Biopharma Montelukast Intermediate Product
Table 94. Manus Aktteva Biopharma Recent Development
Table . Ortin Laboratories Corporation Information
Table . Ortin Laboratories Description and Business Overview
Table . Ortin Laboratories Montelukast Intermediate Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table . Ortin Laboratories Montelukast Intermediate Product
Table . Ortin Laboratories Recent Development
Table 100. Production Base and Market Concentration Rate of Raw Material
Table 101. Key Suppliers of Raw Materials
Table 102. Montelukast Intermediate Distributors List
Table 103. Montelukast Intermediate Customers List
Table 104. Market Key Trends
Table 105. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 106. Key Challenges
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Montelukast Intermediate Product Picture
Figure 2. Global Montelukast Intermediate Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Montelukast Intermediate Market Share by Application in 2020 & 2026
Figure 6. Asthma Examples
Figure 7. Allergic Rhinitis Examples
Figure 8. Bronchospasm Examples
Figure 9. Urticaria Examples
Figure 10. Global Montelukast Intermediate Sales (MT) Growth Rate (2015-2026)
Figure 11. Global Montelukast Intermediate Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Montelukast Intermediate Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 13. Global Montelukast Intermediate Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Montelukast Intermediate Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Montelukast Intermediate Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Montelukast Intermediate Sales (MT) Growth Rate (2015-2026)
Figure 17. Europe Montelukast Intermediate Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Montelukast Intermediate Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Montelukast Intermediate Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Montelukast Intermediate Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Montelukast Intermediate Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Montelukast Intermediate Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Montelukast Intermediate Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Montelukast Intermediate Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Montelukast Intermediate Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Montelukast Intermediate Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Montelukast Intermediate Players Market Share by Revenue in Montelukast Intermediate 2015 & 2019
Figure 28. Montelukast Intermediate Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Montelukast Intermediate Revenue Share by Type (2015-2020)
Figure 30. Global Montelukast Intermediate Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Montelukast Intermediate Revenue Share by Application (2015-2020)
Figure 32. Global Montelukast Intermediate Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Montelukast Intermediate Sales Market Share by Type in 2019
Figure 34. United States Montelukast Intermediate Sales Market Share by Type in 2019
Figure 35. Europe Montelukast Intermediate Sales Market Share by Company in 2019
Figure 36. Europe Montelukast Intermediate Sales Market Share by Type in 2019
Figure 37. Europe Montelukast Intermediate Sales Market Share by Application in 2019
Figure 38. China Montelukast Intermediate Sales Market Share by Company in 2019
Figure 39. China Montelukast Intermediate Sales Market Share by Type in 2019
Figure 40. China Montelukast Intermediate Sales Market Share by Application in 2019
Figure 41. Japan Montelukast Intermediate Sales Market Share by Company in 2019
Figure 42. Japan Montelukast Intermediate Sales Market Share by Type in 2019
Figure 43. Japan Montelukast Intermediate Sales Market Share by Application in 2019
Figure 44. Southeast Asia Montelukast Intermediate Sales Market Share by Company in 2019
Figure 45. Southeast Asia Montelukast Intermediate Sales Market Share by Type in 2019
Figure 46. Southeast Asia Montelukast Intermediate Sales Market Share by Application in 2019
Figure 47. India Montelukast Intermediate Sales Market Share by Company in 2019
Figure 48. India Montelukast Intermediate Sales Market Share by Type in 2019
Figure 49. India Montelukast Intermediate Sales Market Share by Application in 2019
Figure 50. VIVAN Life Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. P.G. Shah & Co. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Manus Aktteva Biopharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Ortin Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Key Raw Materials Price Trend
Figure 55. Manufacturing Cost Structure of Montelukast Intermediate
Figure 56. Manufacturing Process Analysis of Montelukast Intermediate
Figure 57. Montelukast Intermediate Industrial Chain Analysis
Figure 58. Channels of Distribution
Figure 59. Distributors Profiles
Figure 60. Porter's Five Forces Analysis
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
モンテルカストナトリウムの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Montelukast Sodium market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…- 農薬中間体の世界市場レポート2020 Pesticide intermediates are pesticides active ingredients prevents pests. Market Analysis and Insights: Global Pesticide intermediate Market Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declarin…
- HALS中級の世界市場レポート2020 A fine chemical used to synthesize a light stabilizer Market Analysis and Insights: Global HALS Intermediate Market Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emer…
- プラスチック硬質中間バルクコンテナの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Plastic Rigid Intermediate Bulk Containers market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Pl…
- FIBC（フレキシブル中間バルクコンテナー）の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The FIBC (Flexible Intermediate Bulk Container) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, val…